Exhibit 10.1
EXECUTION VERSION
THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT
THIS THIRD AMENDMENT TO THE LOAN AND SECURITY AGREEMENT(this “Amendment”), is made as of December 31, 2020, by and among OAKTREE STRATEGIC INCOME II, INC., as the collateral manager (in such capacity, the “Collateral Manager”), OSI 2 SENIOR LENDING SPV, LLC, as the borrower (the “Borrower”), Citibank, N.A., as administrative agent (the “Administrative Agent”) and Citibank, N.A., as the sole committed lender (the “Lender”).
R E C I T A L S
WHEREAS, the Collateral Manager, Oaktree Strategic Income II, Inc., as the seller (in such capacity, the “Seller”), the Borrower, the Administrative Agent, the Lender and Deutsche Bank Trust Company Americas, as Collateral Agent, are parties to that certain Loan and Security Agreement, dated as of July 26, 2019 (as the same has been previously amended and may be amended, modified, waived, supplemented, restated or replaced from time to time, the “Loan and Security Agreement”);
WHEREAS, pursuant to Section 13.1 of the Loan and Security Agreement, the Collateral Manager and the Borrower desire to, and have requested that the Administrative Agent agree to, amend certain provisions of the Loan and Security Agreement as provided herein;
WHEREAS, subject to the terms and conditions of this Amendment, the Administrative Agent and Lenders constituting at least the Required Lenders are willing to agree to such amendments to the Loan and Security Agreement.
NOW THEREFORE, in consideration of the premises and the mutual covenants hereinafter contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
1. Defined Terms. Capitalized terms used in this Amendment and not otherwise defined herein shall have the meanings ascribed thereto in the Loan and Security Agreement.
2. Amendments. The Loan and Security Agreement is hereby amended, modified and supplemented as follows:
(A) The defined term “Concentration Limits” in Section 1.1 is hereby amended by deleting clause (b)(i) and b(ii) thereof and replacing each with the following (underlined shows the changes for convenience of reference):
(i) in the Industry with the highest aggregate Outstanding Balances shall not exceed 20.0% of the Concentration Test Amount; provided that if the Industry with the highest aggregate Outstanding Balances is “High Tech Industries,” 25.0% of the Concentration Test Amount;
(ii) in the Industry with the second highest aggregate Outstanding Balances shall not exceed 17.5% of the Concentration Test Amount; provided that if the Industry with the second highest aggregate Outstanding Balances is “Healthcare & Pharmaceuticals,” 20.0% of the Concentration Test Amount;
(B) Section 1.1 is hereby amended by adding the following defined terms in the appropriate alphabetical order:
“Second Upsize Amount” means $50,000,000.